6 Results for "

BOK

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "BOK" in MCE Product Catalog:

Cat. No.: HY-RS18323
Research Areas:  

Others

Bok Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bok gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS01570
Research Areas:  

Others

BOK Human Pre-designed siRNA Set A contains three designed siRNAs for BOK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24801
Research Areas:  

Others

Bok Rat Pre-designed siRNA Set A contains three designed siRNAs for Bok gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P82544
Synonyms: BOKL; BCL2L9

Host:  

Rabbit

Application:  

WB, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P82544A
Synonyms: BOKL; BCL2L9

Host:  

Rabbit

Application:  

WB, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-113720
CAS No.: 1041469-97-9
RKS262 is an orally active cyclin/CDK inhibitor. RKS262 is also an apoptosis inducer and cell cycle regulator, exhibiting cytotoxic activity against cancer cells. RKS262 induces caspase-3 cleavage, ROS generation, SAPK/JNK activation, and upregulates the expression of p53, Bid, Bad, Bok, and p27. RKS262 inhibits the expression of Bcl-2, Mcl-1, Bcl-xL, p21, cyclin D1, cyclin B1, cdc-2, cyclin D4, and DNA-pk KU-80 subunit. RKS262 suppresses the phosphorylation of the IGF-1R/PI3K/PKC pathway, ras oncogene activity, and Cdk-6, while increasing total Akt expression. RKS262 induces G2/M or S phase cell cycle arrest, disrupts mitochondrial transmembrane potential, and reduces tumor burden in xenograft models. RKS262 is used in research on neuroblastoma and ovarian cancer .
loading...
    loading...